SUPN FY2025 SEC EDGAR DEF 14A #52 of 168 in industry

Supernus Pharmaceuticals, Inc. CEO pay ratio

The CEO earned $15.5M in FY2025 against median worker pay of $192,397 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-30
Industry
Chemicals & Pharmaceuticals
Industry rank
#52/168

Data updated August 2026

Subscribe to Supernus Pharmaceuticals, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
81:1
Moderate (Scale: 0–1000:1)
CEO pay
$15.5M
Median worker
$192,397

Answer first

Supernus Pharmaceuticals, Inc.'s FY2025 CEO total of $15.5M ranks #284 of 1,423 complete filings; its 81:1 pay ratio ranks #757. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $192,397. Industry placement uses the FY2025 SIC-28 peer cohort (# 52 of 168, 70th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#284
$15.5M of 1,423 FY2025
Ratio rank
#757
81:1 of 1,423
Industry pct
70th
above the industry median pay ratio

How Supernus Pharmaceuticals, Inc. ranks nationally

Supernus Pharmaceuticals, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$15,501,556 Top 20% higher than 80% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). This entry sits in this band. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Supernus Pharmaceuticals, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($15.5M) against pay ratio (81:1) for Supernus Pharmaceuticals, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3477847.28104765.11273168317358600.921985518.839.9:151.7:163.5:175.3:187.2:1CEO total payPay ratio (CEO : median worker)Supernus Pharmaceuticals, Inc., CEO total pay: 15501556 · Pay ratio (CEO : median worker): 81:1Supernus Pharmaceuticals, Inc.Repligen Corp, CEO total pay: 6114771 · Pay ratio (CEO : median worker): 82:1Repligen CorpVertex Pharmaceuticals Inc / Ma, CEO total pay: 21144261 · Pay ratio (CEO : median worker): 80:1Vertex Pharmaceuticals Inc / MaLantheus Holdings, Inc., CEO total pay: 15346066 · Pay ratio (CEO : median worker): 79:1Lantheus Holdings, Inc.Avient Corp, CEO total pay: 5818257 · Pay ratio (CEO : median worker): 85:1Avient CorpUsana Health Sciences Inc, CEO total pay: 4319105 · Pay ratio (CEO : median worker): 85:1Usana Health Sciences Inc
Supernus Pharmaceuticals, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Supernus Pharmaceuticals, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Supernus Pharmaceuticals, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
81:1
FY2025
vs prior FY
-26:1
from FY2024 107:1
CEO $ YoY
-13%
$15.5M latest
Filings shown
5
FY2021–2025
Supernus Pharmaceuticals, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $8.1M - $128,385 63:1 -
2022 $10.0M +23% $164,299 61:1 -2:1
2023 $13.3M +33% $165,817 80:1 +19:1
2024 $17.8M +34% $166,121 107:1 +27:1
2025 $15.5M -13% $192,397 81:1 -26:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1356576, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
81:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$15.5M
Companies in Industry
168
vs. Industry Median
Above
#52 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Supernus Pharmaceuticals, Inc.: MID · PEAK pay ratio

Supernus Pharmaceuticals, Inc.'s FY2025 ratio 81:1 ranks #52 of 168 Chemicals & Pharmaceuticals filers (70th percentile). the CEO earned 81× the median employee ($192,397) in FY2025.

Median employee $192,397 (ELITE-MED); MID · PEAK stamps put about 81 median-wage years per CEO year.

CEO Total Pay

$15.5M

FY2025 Summary Compensation, above median

Pay Ratio

81:1

Near industry median

Supernus Pharmaceuticals, Inc. in the higher Chemicals & Pharmaceuticals third

Supernus Pharmaceuticals, Inc.'s FY2025 ratio 81:1 ranks #52 of 168 Chemicals & Pharmaceuticals filers (70th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Supernus Pharmaceuticals, Inc.'s $15.5M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #284 and ratio rank #757 split - treat 81:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$15.5M
Median Employee Pay
$192,397
Pay Ratio
81:1
Filing Date
2026-04-30

Company Info

Ticker
SUPN
CIK
1356576
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1356576, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Supernus Pharmaceuticals, Inc.'s FY2025 ratio 81:1 ranks #52 of 168 Chemicals & Pharmaceuticals filers (70th percentile).

Read with Supernus Pharmaceuticals, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · PEAK · ELITE-MED.

Walker & Dunlop, Inc. · PEAK

ABS(ceo_total_comp) peer at $15.5M (Δ $1K lighter vs Supernus Pharmaceuticals, Inc.); MID · ELITE-MED vs this page's MID · PEAK · ELITE-MED.
Quest Diagnostics Inc · PEAK

ABS(ceo_total_comp) peer at $15.5M (Δ $20K heavier vs Supernus Pharmaceuticals, Inc.); STEEP · PAR-MED vs this page's MID · PEAK · ELITE-MED.
Exelon Corp · PEAK

ABS(ceo_total_comp) peer at $15.5M (Δ $42K heavier vs Supernus Pharmaceuticals, Inc.); MID · ELITE-MED vs this page's MID · PEAK · ELITE-MED.
Chipotle Mexican Grill Inc · PEAK

ABS(ceo_total_comp) peer at $15.5M (Δ $44K lighter vs Supernus Pharmaceuticals, Inc.); EXTREME · LOW-MED vs this page's MID · PEAK · ELITE-MED.
Repligen Corp (SIC 28 pole)

Repligen Corp stamps MID · HEAVY nearest in-SIC by ABS(pay_ratio) to Supernus Pharmaceuticals, Inc.'s MID filing.
National dual ranks · #284/#757

Supernus Pharmaceuticals, Inc.'s FY2025 package sits #284 by CEO dollars and #757 by ratio under PEAK · MID.
Comp structure · PEAK

Supernus Pharmaceuticals, Inc.'s PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Supernus Pharmaceuticals, Inc. (CIK 1356576), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.